How HIV may escape the activating effects of TNF.
Virelizier
J L
JL
Institut Pasteur, Paris.
D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D002460:Cell Line; D006678:HIV / Q000235:genetics / Q000276:immunology*; D016325:HIV Long Terminal Repeat / Q000235:genetics; D006801:Humans; D009000:Monocytes; D016328:NF-kappa B / Q000096:biosynthesis; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D014158:Transcription, Genetic / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*
D016328:NF-kappa B; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha